US health regulators are advocating for more comprehensive data on testosterone therapy for women highlighting a significant gap in FDA-approved options Officials from the FDA emphasize that while foreign data can be utilized it must meet stringent US standards This call to action aims to encourage companies to submit applications for products tailored to women